CVS Health Corporation
CVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $57 | $101 | $122 | $136 |
| - Cash | $9 | $8 | $13 | $9 |
| + Debt | $83 | $79 | $71 | $76 |
| Enterprise Value | $131 | $173 | $180 | $203 |
| Revenue | $373 | $358 | $322 | $292 |
| % Growth | 4.2% | 10.9% | 10.4% | – |
| Gross Profit | $51 | $54 | $55 | $52 |
| % Margin | 13.8% | 15.2% | 16.9% | 17.8% |
| EBITDA | $14 | $18 | $12 | $18 |
| % Margin | 3.7% | 5.1% | 3.8% | 6% |
| Net Income | $5 | $8 | $4 | $8 |
| % Margin | 1.2% | 2.3% | 1.3% | 2.7% |
| EPS Diluted | 3.66 | 6.47 | 3.26 | 5.95 |
| % Growth | -43.4% | 98.5% | -45.2% | – |
| Operating Cash Flow | $9 | $13 | $16 | $18 |
| Capital Expenditures | -$3 | -$3 | -$3 | -$3 |
| Free Cash Flow | $6 | $10 | $13 | $16 |